Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo O...

por Aloumanis, K., Karras, D., Drossinos, V., Korelis, E., Polydorakis, A.
Publicado 2011

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

por Fahrleitner-Pammer, A., Langdahl, B. L., Marin, F., Jakob, F., Karras, D., Barrett, A., Ljunggren, Ö., Walsh, J. B., Rajzbaum, G., Barker, C., Lems, W. F.
Publicado 2010

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study

por Jakob, F, Oertel, H, Langdahl, B, Ljunggren, O, Barrett, A, Karras, D, Walsh, J B, Fahrleitner-Pammer, A, Rajzbaum, G, Barker, C, Lems, W F, Marin, F
Publicado 2012

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study

por Jakob, F, Oertel, H, Langdahl, B, Ljunggren, O, Barrett, A, Karras, D, Walsh, J B, Fahrleitner-Pammer, A, Rajzbaum, G, Barker, C, Lems, W F, Marin, F
Publicado 2012